Session 2010 - 11
Internet Publications
Other Bills before Parliament

Health and Social Care Bill


Health and Social Care Bill
Schedule 4 — Amendments of the National Health Service Act 2006
Part 6 — Ophthalmic services

276

 

56         

In section 118 (persons eligible to enter into general ophthalmic services

contracts), in subsection (1), for “A Primary Care Trust” substitute “The

Board”.

57         

In section 119 (exclusion of contractors), for “a Primary Care Trust”

substitute “the Board”.

5

58         

In section 120 (general ophthalmic services contracts: payments), in

subsection (3)(d), for “a Primary Care Trust” substitute “the Board”.

59         

In section 121 (general ophthalmic services contracts: other required terms),

in subsection (3)(a), for “a Primary Care Trust” substitute “the Board”.

60    (1)  

Section 123 (persons performing primary ophthalmic services) is amended

10

as follows.

      (2)  

In the following provisions, for “a Primary Care Trust” substitute “the

Board”—

(a)   

subsection (1), in each place it occurs,

(b)   

subsection (3)(j),

15

(c)   

subsection (4)(a), (b) and (d), and

(d)   

subsection (7)(a) and (b).

      (3)  

In subsection (2), for paragraph (b) substitute—

“(b)   

the Board is responsible for an ophthalmic service if it secures

its provision by or under any enactment.”

20

      (4)  

In subsection (3), in paragraph (c), omit the words from “as to” to “, and”.

61    (1)  

Section 124 (primary ophthalmic services: assistance and support) is

amended as follows.

      (2)  

In subsection (1)—

(a)   

for “A Primary Care Trust” substitute “The Board”, and

25

(b)   

at the end insert “or primary ophthalmic services that fall within

section 115(4)”.

      (3)  

In subsection (2), for “a Primary Care Trust” substitute “the Board”, and for

“the Primary Care Trust” substitute “the Board”.

62    (1)  

Section 125 (Local Optical Committees) is amended as follows.

30

      (2)  

In subsection (1), for the words from the beginning to “other Primary Care

Trusts” substitute “The Board may recognise a committee formed for an

area”.

      (3)  

In subsection (3)—

(a)   

in paragraph (a), omit “, whether under section 115(4)(a), or”, and

35

(b)   

in paragraph (b), for “the Primary Care Trust” substitute “the Board”.

      (4)  

In subsection (7), for “a Primary Care Trust” substitute “the Board”.

      (5)  

In subsection (10)—

(a)   

for “A Primary Care Trust” substitute “The Board”, and

(b)   

in paragraphs (a) and (b), for “the Primary Care Trust” substitute

40

“the Board”.

 
 

Health and Social Care Bill
Schedule 4 — Amendments of the National Health Service Act 2006
Part 7 — Pharmaceutical services

277

 

Part 7

Pharmaceutical services

63    (1)  

Section 126 (arrangements for pharmaceutical services) is amended as

follows.

      (2)  

In subsection (1), for “Each Primary Care Trust” substitute “The Board”.

5

      (3)  

In subsection (3), for the words from “as respects” to “that area” substitute

“for the provision to persons who are in England”.

      (4)  

In subsection (6), for “a Primary Care Trust” substitute “the Board”.

      (5)  

Omit subsection (7).

64    (1)  

Section 127 (arrangements for additional pharmaceutical services) is

10

amended as follows.

      (2)  

In subsections (1)(a) and (b) and (2), for “a Primary Care Trust”, substitute

“the Board”.

      (3)  

In subsection (1)(a), for “within or outside its area” substitute “in England”.

      (4)  

In subsection (2), omit the words from “(whether” to the end.

15

65    (1)  

Section 128 (terms and conditions of arrangements under section 127) is

amended as follows.

      (2)  

In subsection (1), for “the Primary Care Trust to which they apply”

substitute “the Board”.

      (3)  

In subsection (4), for “A Primary Care Trust” substitute “The Board”.

20

      (4)  

In subsection (5), for “a Primary Care Trust” substitute “the Board”.

66    (1)  

Section 129 (regulations as to pharmaceutical services) is amended as

follows.

      (2)  

In subsection (1), for “a Primary Care Trust” substitute “the Board”.

      (3)  

In subsection (2)—

25

(a)   

in paragraph (a)—

(i)   

for “a Primary Care Trust” substitute “the Board”, and

(ii)   

for “the area of the Primary Care Trust” substitute “England”,

(b)   

in paragraph (b), for “a Primary Care Trust” substitute “the Board”,

and

30

(c)   

in paragraph (c), for “the Primary Care Trust” substitute “the Board”.

      (4)  

After subsection (2ZA) (inserted by section 204(3)) insert—

“(2ZB)   

Regulations under subsection (2)(a) may, in particular, require a list

of persons to be prepared by reference to the area in which the

premises from which the services are provided are situated (and

35

regulations imposing that requirement must prescribe the

description of area by reference to which the list is to be prepared).”

      (5)  

In subsection (2A), for “The Primary Care Trust” substitute “The Board”,

      (6)  

In subsections (2C), (3A), (4), (5) and (8), for “the Primary Care Trust”, in

each place it appears, substitute “the Board”.

40

 
 

Health and Social Care Bill
Schedule 4 — Amendments of the National Health Service Act 2006
Part 7 — Pharmaceutical services

278

 

      (7)  

In subsection (6)—

(a)   

in paragraphs (za), (a), (b), (c), (d), (g), (h), (i), (j) and (k), for “a

Primary Care Trust” substitute “the Board”,

(b)   

in paragraphs (b), (e) and (k), for “the Primary Care Trust”, in each

place it appears, substitute “the Board”, and

5

(c)   

in paragraph (f), for “that Primary Care Trust” substitute “the

Board”.

      (8)  

In subsection (6)(c)—

(a)   

for “the Primary Care Trust”, in the first place it appears, substitute

“the Board”, and

10

(b)   

omit “in the area of the Primary Care Trust”.

      (9)  

In subsection (10A), for “Primary Care Trusts” substitute “The Board”.

67         

In section 130 (regulations about appeals from decisions on applications for

inclusion in pharmaceutical list), in subsection (2)—

(a)   

for “a Primary Care Trust” substitute “the Board”, and

15

(b)   

for “the Primary Care Trust” substitute “the Board”.

68    (1)  

Section 131 (power to charge fee to applicants) is amended as follows.

      (2)  

In subsection (1), for “a Primary Care Trust” substitute “the Board”.

      (3)  

In subsections (2)(b), (3)(b) and (5), for “the Primary Care Trust” substitute

“the Board”.

20

      (4)  

In subsection (3)(a), omit the words from “and such” to the end.

69    (1)  

Section 132 (persons authorised to provide pharmaceutical services) is

amended as follows.

      (2)  

In subsections (1) and (4)(a), (b), (c), (d) and (e), for “a Primary Care Trust”

substitute “the Board”.

25

      (3)  

In subsection (3)—

(a)   

for “each Primary Care Trust” substitute “the Board”, and

(b)   

for “the Primary Care Trust” substitute “the Board”.

      (4)  

In subsection (4), after paragraph (a) insert—

“(aa)   

requiring a list of medical practitioners referred to in

30

subsection (3) to be prepared by reference to an area of a

prescribed description,”.

      (5)  

In subsection (5)—

(a)   

for “a Primary Care Trust” substitute “the Board”, and

(b)   

for “the Primary Care Trust” substitute “the Board”.

35

70    (1)  

Section 133 (inadequate provision of pharmaceutical services) is amended as

follows.

      (2)  

In subsection (1)(a)—

(a)   

for “the area, or part of the area, of a Primary Care Trust” substitute

“any part of England”, and

40

(b)   

omit “area or”.

      (3)  

In subsection (1)(b), for “any such area or part” substitute “any part of

England”.

 
 

Health and Social Care Bill
Schedule 4 — Amendments of the National Health Service Act 2006
Part 7 — Pharmaceutical services

279

 

      (4)  

In subsection (2)(a), for “the Primary Care Trust” substitute “the Board”.

71    (1)  

Section 134 (pilot schemes) is amended as follows.

      (2)  

In subsection (1), for “Primary Care Trusts” substitute “The Board”.

      (3)  

In subsection (2)—

(a)   

in paragraph (a), for “a Primary Care Trust” substitute “the Board”,

5

(b)   

after that paragraph insert “and”,

(c)   

in paragraph (b), omit “(otherwise than by the Primary Care Trust)”,

and

(d)   

omit paragraph (c) and the preceding “and”.

      (4)  

In subsection (5), for “a Primary Care Trust” substitute “the Board”.

10

72         

In section 136 (designation of priority neighbourhoods or premises), in

subsections (1) and (2)(b), for “a Primary Care Trust” substitute “the Board.”

73         

In section 137 (reviews of pilot schemes), in subsection (3)(a), for “the

Primary Care Trust concerned” substitute “the Board”.

74    (1)  

Section 138 (variation and termination of pilot schemes) is amended as

15

follows.

      (2)  

In subsection (1), for “Primary Care Trusts” substitute “the Board”.

      (3)  

In subsections (2) and (3), for “the Primary Care Trust concerned” substitute

“the Board”.

75    (1)  

Section 140 (funding of preparatory work) is amended as follows.

20

      (2)  

In subsection (1), for “Primary Care Trusts” substitute “the Board”.

      (3)  

In subsection (3)(b) and (c), for “a Primary Care Trust” substitute “the

Board”.

76    (1)  

In section 144 (local pharmaceutical services schemes)—

(a)   

for “Primary Care Trusts” substitute “the Board or the Secretary of

25

State”, and

(b)   

omit “or Strategic Health Authorities”.

      (2)  

In consequence of the repeal made by sub-paragraph (1)(b), omit section

29(4) of the Health Act 2009.

77    (1)  

Section 148 (conditional inclusion in pharmaceutical lists) is amended as

30

follows.

      (2)  

In subsection (1), in paragraph (a), for “the Primary Care Trust in whose list

he is included” substitute “the Board”.

      (3)  

In subsections (1)(b), (c) and (e), (3)(a) and (b)(ii) and (iii) and (4), for “the

Primary Care Trust”, in each place it appears, substitute “the Board”.

35

      (4)  

In subsection (6), for “a Primary Care Trust” substitute “the Board”.

78    (1)  

Section 150A (notices and penalties) is amended as follows.

      (2)  

In subsection (1)—

(a)   

for “a Primary Care Trust” substitute “the Board”, and

(b)   

for “the Primary Care Trust” substitute “the Board”.

40

 
 

Health and Social Care Bill
Schedule 4 — Amendments of the National Health Service Act 2006
Part 7 — Pharmaceutical services

280

 

      (3)  

In subsection (2), for “Primary Care Trusts” substitute “the Board”.

79    (1)  

Section 151 (disqualification of practitioners) is amended as follows.

      (2)  

In subsection (1), for “a Primary Care Trust” substitute “the Board”.

      (3)  

In subsection (5), for “the Primary Care Trust” substitute “the Board”.

      (4)  

In subsection (6), for “The Primary Care Trust” substitute “The Board”.

5

80    (1)  

Section 152 (contingent removal) is amended as follows.

      (2)  

In subsections (1) and (3), for “the Primary Care Trust” substitute “the

Board”.

      (3)  

In subsection (4), for “The Primary Care Trust” substitute “The Board”.

81         

In section 154 (suspension), in subsections (1), (3), (4), (6)(b) and (c) and (8)

10

(in each place it appears), for “the Primary Care Trust” substitute “the

Board”.

82    (1)  

Section 155 (suspension pending removal) is amended as follows.

      (2)  

In subsections (1), (3) and (6), for “the Primary Care Trust” substitute “the

Board”.

15

      (3)  

In subsection (5), for “The Primary Care Trust” substitute “The Board”.

83    (1)  

Section 157 (review of decisions) is amended as follows.

      (2)  

In subsection (1), for “The Primary Care Trust” substitute “The Board”.

      (3)  

In subsections (2)(a) and (3), for “the Primary Care Trust” substitute “the

Board”.

20

84    (1)  

Section 158 (appeals) is amended as follows.

      (2)  

In subsection (1), for “a Primary Care Trust” substitute “the Board”.

      (3)  

In subsections (2) and (6), for “The Primary Care Trust” substitute “The

Board”.

      (4)  

In subsections (3), (4) and (5)(a) and (b) for “the Primary Care Trust”

25

substitute “the Board”.

      (5)  

In subsection (7), for “Primary Care Trusts” substitute “the Board”.

85    (1)  

Section 159 (national disqualification) is amended as follows.

      (2)  

In subsection (1), for “each Primary Care Trust”, in each place it appears,

substitute “the Board”.

30

      (3)  

In subsection (3), for “a Primary Care Trust” substitute “the Board”.

      (4)  

In subsection (4)—

(a)   

for “The Primary Care Trust” substitute “The Board”, and

(b)   

for “the Primary Care Trust” substitute “the Board”.

      (5)  

In subsection (5), for “the Primary Care Trust’s” substitute “the Board’s”.

35

      (6)  

In subsection (6)—

(a)   

in paragraph (a), for “no Primary Care Trust or” substitute “neither

the Board nor a”, and

 
 

Health and Social Care Bill
Schedule 4 — Amendments of the National Health Service Act 2006
Part 7 — Pharmaceutical services

281

 

(b)   

in paragraph (b), for “each Primary Care Trust” substitute “the Board

(if he is included in a list prepared by it)”.

86         

In section 160 (notification of decisions), for “a Primary Care Trust”

substitute “the Board”.

87         

In section 161 (withdrawal from lists), in paragraphs (a) and (b), for “a

5

Primary Care Trust” substitute “the Board”.

88    (1)  

Section 162 (regulations about decisions under Chapter 6 of Part 7) is

amended as follows.

      (2)  

In subsections (1) and (2)(b), for “a Primary Care Trust” substitute “the

Board”.

10

      (3)  

In subsections (2)(c) and (3), for “the Primary Care Trust” substitute “the

Board”.—

89    (1)  

Section 164 (remuneration for persons providing pharmaceutical services) is

amended as follows.

      (2)  

In subsection (3)(b), for “any Primary Care Trust” substitute “the Board”.

15

      (3)  

In subsection (4A)(a), for “a Primary Care Trust” substitute “the Board”.

90    (1)  

Section 166 (indemnity cover) is amended as follows.

      (2)  

In subsection (2)(b)—

(a)   

for “a Primary Care Trust” substitute “the Board”, and

(b)   

for “the Primary Care Trust”, in each place it appears, substitute “the

20

Board”.

      (3)  

In subsection (3), in paragraph (a) of the definition of “indemnity cover”, for

“a Primary Care Trust” substitute “the Board”.

91    (1)  

Section 167 (local pharmaceutical committees) is amended as follows.

      (2)  

In subsection (1), for the words from the beginning to “other Primary Care

25

Trusts,” substitute “The Board may recognise a committee formed for an

area”.

      (3)  

In subsections (2)(a) and (3)(a), omit “in the Primary Care Trust’s area”.

      (4)  

In subsections (2)(a) and (b), (3)(a) and (b), (9), (10) and (11), for “the Primary

Care Trust” substitute “the Board”.

30

      (5)  

In subsections (6) and (7), for “a Primary Care Trust” substitute “the Board”.

      (6)  

In subsection (9), for “A Primary Care Trust” substitute “The Board”.

92    (1)  

Schedule 11 (pilot schemes) is amended as follows.

      (2)  

In paragraph 1 (initiation of pilot schemes), in sub-paragraph (1)(a), for “a

Primary Care Trust” substitute “the Board”.

35

      (3)  

In paragraph 2 (preliminary steps)—

(a)   

in sub-paragraph (1), for “the Primary Care Trust concerned”

substitute “the Board”,

(b)   

in sub-paragraphs (2), (3), (4) and (5)(a) and (b), for “a Primary Care

Trust” substitute “the Board”,

40

 
 

Health and Social Care Bill
Schedule 4 — Amendments of the National Health Service Act 2006
Part 7 — Pharmaceutical services

282

 

(c)   

in sub-paragraph (3)(b), for “the Primary Care Trust” substitute “the

Board”, and

(d)   

in sub-paragraph (5)(d)—

(i)   

for “Primary Care Trusts” substitute “the Board”, and

(ii)   

for “them” substitute “it”.

5

      (4)  

In paragraph 3 (approvals)—

(a)   

in sub-paragraphs (2) and (3)(b), for “the Primary Care Trust”

substitute “the Board”, and

(b)   

in sub-paragraph (3)(a), for “the Primary Care Trust concerned”

substitute “the Board”.

10

      (5)  

In paragraph 4 (preliminary approval)—

(a)   

in sub-paragraphs (1) and (4), for “a Primary Care Trust” substitute

“the Board”, and

(b)   

in sub-paragraph (2), for “The Primary Care Trust” substitute “The

Board”.

15

      (6)  

In paragraph 5 (effect of proposals on existing services)—

(a)   

in sub-paragraph (1)(a)—

(i)   

for “the Primary Care Trust”, in the first place it appears,

substitute “the Board”, and

(ii)   

for “the area of the Primary Care Trust” substitute “the area

20

concerned”,

(b)   

in sub-paragraph (1)(b), for the words from “supplied” to the end

substitute “prepared under sub-paragraph (3)”,

(c)   

in sub-paragraph (3)—

(i)   

for “a Primary Care Trust” substitute “the Board”,

25

(ii)   

for “the area of another Primary Care Trust” substitute

“another area”, and

(iii)   

for “consult that other Primary Care Trust about” substitute

“prepare an assessment of the likely effect on those services

of the implementation of”, and

30

(d)   

omit sub-paragraph (4).

      (7)  

In paragraph 7 (making a scheme)—

(a)   

in sub-paragraphs (1), (2) and (4), for “the Primary Care Trust

concerned” substitute “the Board”, and

(b)   

in sub-paragraph (1), for “the Primary Care Trust must” substitute

35

“the Board must”.

      (8)  

Any pilot scheme under Chapter 2 of Part 7 of the National Health Service

Act 2006 having effect immediately before the commencement of this

paragraph is to continue to have effect as if it had been established by the

Board; and nothing in this paragraph or paragraphs 57 to 61 affects the

40

validity of anything done under or for the purposes of the scheme.

93    (1)  

Schedule 12 (LPS schemes) is amended as follows.

      (2)  

In paragraph 1 (provision of local pharmaceutical services)—

(a)   

in sub-paragraph (1)—

(i)   

for “Primary Care Trusts” substitute “The Board or the

45

Secretary of State”, and

(ii)   

omit “or Strategic Health Authorities”,

 
 

 
previous section contents continue
 

© Parliamentary copyright
Revised 1 April 2011